| Revenue | {{ Info.Revenue | formatUSD }} |
| Headquarters | {{ Info.Headquarters }} |
| As of Date | 03/27/2024 |
| Adviser Type - Large advisory firm | |
| Number of Employees | 8 14.29% |
| of those in investment advisory functions | 7 16.67% |
| Registration | SEC, Approved, 12/19/2003 |
| AUM* | 647,896,107 19.38% |
| of that, discretionary | 647,896,107 19.38% |
| Private Fund GAV* | 647,896,107 -40.18% |
| Avg Account Size | 161,974,027 19.38% |
| SMA’s | No |
| Private Funds | 6 |
| Contact Info | 310 xxxxxxx |
| Websites |
- Pooled investment vehicles
- Portfolio management for pooled investment vehicles
- A percentage of assets under your management
- Performance-based fees
| Fund Type | Count | GAV |
|---|---|---|
| Fund TypeHedge Fund | Count6 | GAV$647,896,107 |
| Adviser | Hedge Fund | Liquidity Fund | Private Equity Fund | Real Estate Fund | Securitized Asset Fund | Venture Capital Fund | Other Fund | Total Private Fund GAV | AUM | #Funds | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adviser AR ASSET MANAGEMENT, INC. | Hedge Fund154.0m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV154.0m | AUM573.2m | #Funds3 | |
| Adviser FORT, L.P. | Hedge Fund85.1m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV85.1m | AUM358.9m | #Funds2 | |
| Adviser ENGLE CAPITAL MANAGEMENT, L.P. | Hedge Fund408.9m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV408.9m | AUM489.4m | #Funds1 | |
| Adviser LOGAN STONE | Hedge Fund552.3m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV552.3m | AUM805.4m | #Funds2 | |
| Adviser SHAH CAPITAL MANAGEMENT | Hedge Fund444.5m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV444.5m | AUM514.6m | #Funds1 | |
| Adviser ORIBEL CAPITAL MANAGEMENT, LP | Hedge Fund101.0m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV101.0m | AUM1.2b | #Funds1 | |
| Adviser INCOME PARTNERS ASSET MANAGEMENT (HK) LIMITED | Hedge Fund8.3m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV8.3m | AUM368.3m | #Funds1 | |
| Adviser SOLAS CAPITAL MANAGEMENT, LLC | Hedge Fund102.2m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV102.2m | AUM599.1m | #Funds2 | |
| Adviser RIVA RIDGE CAPITAL MANAGEMENT LP | Hedge Fund569.1m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV569.1m | AUM606.8m | #Funds4 | |
| Adviser KEENAN CAPITAL, LLC | Hedge Fund662.1m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV662.1m | AUM662.1m | #Funds1 |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker78464A870 | Stock NameSPDR S&P BIOTECH ETF | $ Position$41,256,414 | % Position10.00% | $ Change1.00% | # Change3.00% |
| Stck Ticker85916J409 | Stock NameSTEREOTAXIS INC | $ Position$24,898,608 | % Position6.00% | $ Change-30.00% | # Change0.00% |
| Stck TickerN5749R100 | Stock NameMERUS N V | $ Position$24,226,861 | % Position6.00% | $ Change42.00% | # Change8.00% |
| Stck Ticker76155X100 | Stock NameREVOLUTION MEDICINES INC | $ Position$19,866,606 | % Position5.00% | $ Change20.00% | # Change0.00% |
| Stck Ticker23282W605 | Stock NameCYTOKINETICS INC | $ Position$21,569,058 | % Position5.00% | $ Change-23.00% | # Change0.00% |
| Stck Ticker45166A102 | Stock NameIDEAYA BIOSCIENCES INC | $ Position$14,823,898 | % Position4.00% | $ Change-24.00% | # Change-5.00% |
| Stck Ticker464287556 | Stock NameISHARES NASDAQ BIOTECH INDX | $ Position$14,069,150 | % Position3.00% | $ Change0.00% | # Change0.00% |
| Stck Ticker87164F105 | Stock NameSYNDAX PHARMACEUTICALS INC | $ Position$13,489,729 | % Position3.00% | $ Change-14.00% | # Change0.00% |
| Stck Ticker04351P101 | Stock NameASCENDIS PHARMA A/S | $ Position$11,042,961 | % Position3.00% | $ Change-21.00% | # Change-12.00% |
| Stck Ticker09627Y109 | Stock NameBLUEPRINT MEDICINES CORP | $ Position$11,291,356 | % Position3.00% | $ Change11.00% | # Change-2.00% |